American International Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

American International Group’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,591	Closed	-$28K	–	3136
2018 Q1	$28K	Sell	2,591 -140	-5%	-$2.25K	﹤0.01%	2974
2017 Q4	$115K	Buy	2,731 +225	+9%	+$10.1K	﹤0.01%	2659
2017 Q3	$138K	Buy	2,506 +187	+8%	+$31.5K	﹤0.01%	2488
2017 Q2	$430K	Buy	2,319 +437	+23%	+$76.6K	﹤0.01%	1804
2017 Q1	$225K	Buy	1,882 +125	+7%	+$13.1K	﹤0.01%	2106
2016 Q4	$175K	Sell	1,757 -4	-0.2%	-$421	﹤0.01%	2277
2016 Q3	$197K	Buy	1,761 +2	+0.1%	+$240	﹤0.01%	2172
2016 Q2	$181K	Buy	1,759 +669	+61%	+$66.9K	﹤0.01%	2192
2016 Q1	$100K	Buy	1,090 +1,027	+1,630%	+$110K	﹤0.01%	3428
2015 Q4	$9K	Hold	63	–	–	﹤0.01%	4551
2015 Q3	$6K	Hold	63	–	–	﹤0.01%	4626
2015 Q2	$10.2K	Buy	+63	New	+$10.7K	﹤0.01%	4591

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American International Group's SIOX Position: Q2 2018 in Review

American International Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 2,591 shares — an estimated $28K sold.

American International Group first reported a position in SIOX in Q2 2015 and held it in 12 quarters. The position peaked at $430K in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

American International Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
American International Group sold 2,591 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $28K.
American International Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 12 quarters.
American International Group's Sio Gene Therapies Inc. Common Stock position peaked at $430K in Q2 2017.
71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on American International Group's 13F filing for Q2 2018, filed 8 Aug 2018.